Easy Find It Page
Easy Find It
Use Our Mobile Site
Use Our Mobile Site
Share This Website
The Sugar Trehalose
Free NEWS Letter
Affiliate Program
Untitled Document

Already an Affiliate? Click on the link below to access your account-

Affiliate Login

Endowment Book Store
The Trehalose Store
Endowment Store Front
Support The Endowment
Enter Amount:
We Accept
VisaMaster CardAmerican ExpressDiscoverssl lock
Download Store

Download Store

Download 7 Free Newsletters Plus Other Educational Materials

Main Menu
Home
- - - - - - -
Inside the Human Cell
The Sugar Trehalose
- - - - - - -
Sugar Science Forum
Glycomics Training
Interactive Glycomics Brochure
NEWS
7 FREE NEWSletters
HOT Links of Interest
- - - - - - -
Contact Us
Disclaimer
Sitemap
Educational e-textbook
Chapter One

Chapter One

FREE Sneek Peek
Chapter One


Evaluation Forms

Huntington’s General
Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Parkinson's General
Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Alzheimer / Dementia
General Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Diabetic Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

General Public Health
Evaluation FORM for
Trehalose Nutritional
Pilot Survey (For General
Public without Huntington’s,
Alzheimer’s, or Parkinson’s.)

Who's Online
We have 208 guests online
Federal Jury Rules in Favor Merck
NEW ORLEANS


A federal jury ruled in favor Merck & Co. Inc. on Tuesday in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man's heart attack.

The jury, made up of six women and two men, deliberated for only about two hours before reaching a verdict in the case.

Robert Garry Smith, 56, claimed in U.S. District Court that the drug contributed to a heart attack he had 3 1/2 years ago. He had taken Vioxx for knee pain for about 4 1/2 months but didn't realize at the time of the heart attack that Vioxx may have been a cause for concern.

Vioxx went on the market in 1999; Merck pulled it two years ago, after a study found a greater risk of heart attack in those who had taken the drug continually for at least 18 months than in those who had taken placebos.

Smith's case is the third federal lawsuit against Merck to go to trial; it began two weeks ago.

Including the verdict Tuesday, the drugmaker so far has amassed a five-and-four record in state and federal courts in Vioxx-related cases. A sixth case Merck won was overturned by a judge and is set to be retried. At least 14,200 cases are pending nationwide.

Source Breitbart.com